BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21860085)

  • 21. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
    Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
    Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.
    Rockenstein E; Ubhi K; Pham E; Michael S; Doppler E; Novak P; Inglis C; Mante M; Adame A; Alvarez XA; Moessler H; Masliah E
    J Neurosci Res; 2011 Nov; 89(11):1812-21. PubMed ID: 21793038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hAβPPSwInd-J20 mouse.
    Fu Y; Rusznák Z; Kwok JB; Kim WS; Paxinos G
    J Alzheimers Dis; 2014; 41(4):1177-92. PubMed ID: 24787919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.
    Rolyan H; Scheffold A; Heinrich A; Begus-Nahrmann Y; Langkopf BH; Hölter SM; Vogt-Weisenhorn DM; Liss B; Wurst W; Lie DC; Thal DR; Biber K; Rudolph KL
    Brain; 2011 Jul; 134(Pt 7):2044-56. PubMed ID: 21672962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
    Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
    Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
    Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
    Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
    Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
    Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.
    Wang CY; Zheng W; Wang T; Xie JW; Wang SL; Zhao BL; Teng WP; Wang ZY
    Neuropsychopharmacology; 2011 Apr; 36(5):1073-89. PubMed ID: 21289607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shenzao jiannao oral liquid, an herbal formula, ameliorates cognitive impairments by rescuing neuronal death and triggering endogenous neurogenesis in AD-like mice induced by a combination of Aβ42 and scopolamine.
    Xiao H; Li H; Song H; Kong L; Yan X; Li Y; Deng Y; Tai H; Wu Y; Ni Y; Li W; Chen J; Yang J
    J Ethnopharmacol; 2020 Sep; 259():112957. PubMed ID: 32416248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB axis: relevance for Alzheimer's disease.
    Meneghini V; Bortolotto V; Francese MT; Dellarole A; Carraro L; Terzieva S; Grilli M
    J Neurosci; 2013 Apr; 33(14):6047-59. PubMed ID: 23554486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.
    Zhang C; McNeil E; Dressler L; Siman R
    Exp Neurol; 2007 Mar; 204(1):77-87. PubMed ID: 17070803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound.
    Baazaoui N; Iqbal K
    Alzheimers Res Ther; 2017 Jun; 9(1):45. PubMed ID: 28655344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease.
    Ye M; Chung HS; An YH; Lim SJ; Choi W; Yu AR; Kim JS; Kang M; Cho S; Shim I; Bae H
    Mol Neurobiol; 2016 Oct; 53(8):5401-12. PubMed ID: 26446019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
    Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
    Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of interneuron populations and correlation with amyloid-β deposition in the olfactory cortex of an AβPP/PS1 transgenic mouse model of Alzheimer's disease.
    Saiz-Sanchez D; Ubeda-Bañon I; De la Rosa-Prieto C; Martinez-Marcos A
    J Alzheimers Dis; 2012; 31(1):113-29. PubMed ID: 22543847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide.
    Bolognin S; Blanchard J; Wang X; Basurto-Islas G; Tung YC; Kohlbrenner E; Grundke-Iqbal I; Iqbal K
    Acta Neuropathol; 2012 Jan; 123(1):133-51. PubMed ID: 22083255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.